Interactions of Ademetionine with Other Medications

Ademetionine rarely causes classic pharmacokinetic interactions through liver enzymes. However, it actively intervenes in the metabolism of neurotransmitters and in the methionine cycle, and this creates its own risks. The editorial team examined which drugs and supplements require special attention when combined with ademetionine, and why.

Types of ademetionine interactions

Drug interactions are divided into pharmacokinetic and pharmacodynamic. Pharmacokinetic ones change the concentration of a drug in the blood — for example, through inhibition or induction of cytochrome P450 enzymes. Pharmacodynamic ones arise when two agents act on the same body system and their effects add up or oppose one another.

For ademetionine, no clinically significant pharmacokinetic interactions through cytochrome P450 have been described. It is metabolized in the methionine cycle, like the body’s own SAMe. So the main attention is focused on pharmacodynamic interactions — primarily in the nervous system.

The second important dimension is biochemical interrelationships. Ademetionine is closely linked with vitamins B12, B6 and folate, and also with the metabolism of drugs that themselves require methylation. Here a combination can both strengthen and weaken effects.

The third dimension is the effect on laboratory tests. Formally this is not a drug interaction, but in practice it can lead to incorrect clinical decisions, so we will mention it as well.

Serotonergic drugs: the main risk

SAMe takes part in the synthesis and metabolism of monoamines — serotonin, dopamine, noradrenaline. This explains its antidepressant action, and it is exactly this that makes the combination with other serotonergic agents potentially dangerous. An excess of serotonin activity can lead to serotonin syndrome.

The medical literature describes a case of serotonin syndrome in a patient who was receiving ademetionine together with the tricyclic antidepressant clomipramine. The package inserts of ademetionine preparations recommend caution when combining it with antidepressants, as well as with herbal agents that affect serotonin.

The symptoms of serotonin syndrome vary from mild to life-threatening: restlessness, tremor, sweating, diarrhea, rapid heartbeat, muscle twitching and rigidity, a rise in temperature. If they appear after starting SAMe or adding a new drug, urgent medical help is needed.

In studies where SAMe was added to SSRIs (Papakostas et al., 2010), such a combination was used under the supervision of psychiatrists with careful selection of participants. Combining SAMe with antidepressants “to enhance the effect” on your own is unacceptable.

Levodopa, stimulants and other agents

Levodopa, used in Parkinson’s disease, in the course of its metabolism is methylated by the enzyme catechol-O-methyltransferase using SAMe as a methyl donor. This leads to the consumption of ademetionine and the accumulation of homocysteine in patients receiving levodopa. At the same time there is a theoretical assumption that additional SAMe may enhance the methylation of levodopa and reduce its effectiveness.

The clinical data on this interaction are limited and contradictory, so there are no definitive conclusions. The practical rule is simple: patients with Parkinson’s disease should discuss any use of SAMe with a neurologist.

Stimulants — caffeine in large doses, synephrine, pre-workout complexes, and also prescription psychostimulants — can enhance such side effects of SAMe as anxiety, insomnia and rapid heartbeat. For athletes who combine several stimulating products, this is especially relevant.

As for alcohol: ademetionine does not neutralize its toxic effect. It was studied specifically in patients with alcoholic liver disease, but the effect, if it exists at all, appeared against the background of treatment rather than continued drinking. The combination of “SAMe as cover for alcohol” has no scientific basis.

• Anticoagulants:no significant interaction has been described, but any change of regimen should be coordinated with a doctor.
• Ursodeoxycholic acid:in the practice of treating cholestasis it is sometimes combined with SAMe on a doctor’s prescription.
• Anabolic steroids and other hepatotoxic substances:SAMe does not eliminate their toxicity.

Vitamins and supplements: synergy and duplication

The work of the methionine cycle depends on vitamins B12 and folate (remethylation of homocysteine) and vitamin B6 (transsulfuration). With their deficiency homocysteine accumulates, and the effectiveness of exogenous SAMe may decrease. That is exactly why the package inserts of ademetionine state that in risk groups it is worth checking the level of B12 and folate.

Betaine (trimethylglycine) and choline are also methyl donors and take part in an alternative pathway of homocysteine remethylation. Combining them with SAMe is not described as dangerous, but it may be redundant. Before adding several “methylating” supplements at once, it is worth assessing whether there is a real need for it.

Creatine is a separate interesting case. Its own synthesis consumes a significant share of SAMe’s methyl groups, so taking creatine as a supplement reduces this expenditure. There is no harmful interaction here; on the contrary, from a biochemical standpoint creatine “unloads” the methionine cycle.

Supplements with methionine in large doses are not recommended without need: an excess of methionine can raise the homocysteine level, especially with insufficient intake of B group vitamins.

A practical checklist before starting

The most common cause of dangerous interactions is not rare pharmacology, but the fact that the doctor does not know about all the agents a person is taking. Athletes often consider supplements “not medications” and do not mention them at an appointment.

• Make a complete list: prescription drugs, over-the-counter agents, supplements, herbal teas and tinctures.
• Separately mark everything that affects mood, sleep, pain or migraine.
• Tell the doctor about bipolar disorder in yourself or close relatives.
• Before a homocysteine test, warn the laboratory about taking SAMe: the drug may give falsely elevated results with immunochemical methods.
• Do not add new serotonergic agents while taking SAMe without a consultation.

If you are already taking an antidepressant and are considering SAMe, the decision must be made by the psychiatrist managing your treatment. They can assess the potential benefit and arrange monitoring for early signs of adverse reactions.

Finally, remember that the risk of interactions grows with the number of agents taken at the same time. Simplifying the regimen is one of the most effective ways to make it safer.

Editorial conclusions

The main risk of ademetionine interactions is pharmacodynamic: combining it with serotonergic drugs and agents can lead to serotonin syndrome.

Interactions through cytochrome P450 enzymes are not clinically significant for SAMe, but the link with levodopa, stimulants and B group vitamins requires attention.

Vitamins B12, B6 and folate do not compete with SAMe but ensure the work of the whole cycle; their deficiency can reduce the drug’s effectiveness.

We also recommend reading our articles “Side effects and contraindications of ademetionine,” “Tests during ademetionine use” and “Ademetionine: the mechanism of action.”

References

1. Papakostas GI, Mischoulon D, Shyu I, et al. S-adenosyl methionine (SAMe) augmentation of serotonin reuptake inhibitors for antidepressant nonresponders with major depressive disorder: a double-blind, randomized clinical trial. Am J Psychiatry. 2010;167(8):942–948.
2. Sharma A, Gerbarg P, Bottiglieri T, et al. S-adenosylmethionine (SAMe) for neuropsychiatric disorders: a clinician-oriented review of research. J Clin Psychiatry. 2017;78(6):e656–e667.
3. Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112–1120.
4. Lu SC, Mato JM. S-adenosylmethionine in liver health, injury, and cancer. Physiol Rev. 2012;92(4):1515–1542.
5. Anstee QM, Day CP. S-adenosylmethionine (SAMe) therapy in liver disease: a review of current evidence and clinical utility. J Hepatol. 2012;57(5):1097–1109.
6. Brosnan JT, Brosnan ME. Creatine: endogenous metabolite, dietary, and therapeutic supplement. Annu Rev Nutr. 2007;27:241–261.